Company Filing History:
2 out of 832,912 Years Active: 2009-2010
Title: John Scott T Jaques: Innovator in Canine Thyroid Research
Introduction
John Scott T Jaques is a notable inventor based in College Station, TX (US). He has made significant contributions to the field of veterinary medicine, particularly in the area of canine health. With a total of 2 patents, his work focuses on innovative solutions for diagnosing and treating canine conditions.
Latest Patents
Jaques' latest patents include the development of recombinant canine thyroid stimulating hormone (rcTSH) and methods of production and use thereof. This invention encompasses a nucleic acid sequence that is at least 98% homologous to SEQ ID NO: 1, encoding the α subunit of canine thyroid stimulating hormone (TSH). Additionally, it includes a nucleic acid sequence that is at least 98% homologous to SEQ ID NO: 2, which encodes the β subunit of canine TSH. The method involves producing a recombinant canine thyroid stimulating hormone subunit by expressing these nucleic acids in a transgenic insect cell modified to sialylate proteins. The resulting sialylated rcTSH subunit can be utilized for both diagnosis and treatment, particularly in diagnosing canine hypothyroidism.
Career Highlights
Throughout his career, Jaques has demonstrated a commitment to advancing veterinary medicine through innovative research. His work has not only contributed to scientific knowledge but has also provided practical applications that benefit canine health.
Collaborations
Jaques has collaborated with Donald L Jarvis, further enhancing the impact of his research in the field.
Conclusion
John Scott T Jaques is a distinguished inventor whose work in developing recombinant canine thyroid stimulating hormone has the potential to significantly improve the diagnosis and treatment of canine hypothyroidism. His contributions to veterinary medicine exemplify the importance of innovation in enhancing animal health.